Literature DB >> 17053361

High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.

Lucy Platt1, Natalia Bobrova, Tim Rhodes, Anneli Uusküla, John V Parry, Kristi Rüütel, Ave Talu, Katri Abel, Kristiina Rajaleid, Ali Judd.   

Abstract

We found a high prevalence of HIV among injecting drug users (IDU) 54% in Tallinn and 90% in Kohtla Jarve, Estonia. Risk factors for HIV in Tallinn included use of the drug 'china white', being registered as an IDU at a drug treatment clinic, and sharing injecting equipment with sex partners. Differences existed in risk behaviour between the cities. An urgent scale-up of HIV prevention is needed. It is also important to explore how local 'risk environments' mediate the risk of HIV transmission.

Mesh:

Year:  2006        PMID: 17053361     DOI: 10.1097/01.aids.0000247586.23696.20

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  29 in total

1.  Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.

Authors:  Vana Sypsa; Mina Psichogiou; Dimitrios Paraskevis; Georgios Nikolopoulos; Chrissa Tsiara; Dimitra Paraskeva; Katerina Micha; Meni Malliori; Anastasia Pharris; Lucas Wiessing; Martin Donoghoe; Samuel Friedman; Don Des Jarlais; Georgios Daikos; Angelos Hatzakis
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

Review 2.  Toward a comprehensive approach to HIV prevention for people who use drugs.

Authors:  Brandon D L Marshall; Evan Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

3.  HIV/STI prevalence study among military conscripts in Estonia.

Authors:  R David Parker; Michael Regier; Joseph Widmeyer; Kristi Rüütel
Journal:  J Community Health       Date:  2015-04

4.  Complexities of short-term mobility for sex work and migration among sex workers: violence and sexual risks, barriers to care, and enhanced social and economic opportunities.

Authors:  Shira M Goldenberg; Jill Chettiar; Paul Nguyen; Sabina Dobrer; Julio Montaner; Kate Shannon
Journal:  J Urban Health       Date:  2014-08       Impact factor: 3.671

5.  Multiple routes of drug administration and HIV risk among injecting drug users.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Don C Des Jarlais; Katri Abel-Ollo; Ave Talu; Kristi Rüütel
Journal:  J Subst Abuse Treat       Date:  2011-11-23

6.  Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia.

Authors:  Anneli Uusküla; David M Barnes; Mait Raag; Ave Talu; Susan Tross; Don C Des Jarlais
Journal:  Drug Alcohol Depend       Date:  2018-05-08       Impact factor: 4.492

7.  Injecting transition risk and depression among Mexican American non-injecting heroin users.

Authors:  Alice Cepeda; Charles Kaplan; Alan Neaigus; Miguel Ángel Cano; Yolanda Villarreal; Avelardo Valdez
Journal:  Drug Alcohol Depend       Date:  2012-06-30       Impact factor: 4.492

8.  Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Don Des Jarlais
Journal:  J Urban Health       Date:  2009-11-18       Impact factor: 3.671

9.  CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.

Authors:  Kristi Huik; Maarja Sadam; Tõnis Karki; Radko Avi; Tõnu Krispin; Piret Paap; Kristi Rüütel; Anneli Uusküla; Ave Talu; Katri Abel-Ollo; Irja Lutsar
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

10.  Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research.

Authors:  Louise-Anne McNutt; Elisa J Gordon; Anneli Uusküla
Journal:  BMC Med Ethics       Date:  2009-08-27       Impact factor: 2.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.